Larimar Therapeutics Inc. buy melinda
Start price
07.04.16
/
50%
€78.15
Target price
21.07.16
€184.01
Performance (%)
-54.46%
End price
21.07.16
€35.59
Summary
This prediction ended on 21.07.16 with a price of €35.59. Massive losses of -54.46% were the result for the BUY prediction by melinda. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Larimar Therapeutics Inc. | -3.817% | -3.817% | 66.667% | -34.375% |
iShares Core DAX® | 2.291% | 2.984% | 20.344% | 20.143% |
iShares Nasdaq 100 | 1.336% | -0.196% | 25.550% | 37.734% |
iShares Nikkei 225® | 1.132% | 2.488% | 13.163% | 1.261% |
iShares S&P 500 | 1.272% | 1.334% | 24.544% | 40.521% |
According to melinda what are the pros and cons of Larimar Therapeutics Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Zafgen Inc. diskutieren
Stier
a +
(Vom Mitglied beendet)
Stopped prediction by melinda for Larimar Therapeutics Inc.
Larimar Therapeutics Inc.
Start price
Target price
Perf. (%)
€8.94
10.12.19
10.12.19
€13.00
04.11.21
04.11.21
20.81%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Larimar Therapeutics Inc.
Start price
Target price
Perf. (%)
€54.88
07.02.19
07.02.19
€97.42
13.02.19
13.02.19
-11.83%
13.02.19
13.02.19
Could be worthwhile Investment >10% per year
Larimar Therapeutics Inc.
Start price
Target price
Perf. (%)
€87.46
08.03.18
08.03.18
€97.42
25.06.18
25.06.18
16.58%
25.06.18
25.06.18
Could be worthwhile Investment >10% per year
Larimar Therapeutics Inc.
Start price
Target price
Perf. (%)
€44.92
13.05.17
13.05.17
€54.12
14.11.17
14.11.17
-12.05%
14.11.17
14.11.17
Could be worthwhile Investment >10% per year
Larimar Therapeutics Inc.
Start price
Target price
Perf. (%)
€64.73
14.03.16
14.03.16
€81.18
04.04.16
04.04.16
26.76%
04.04.16
04.04.16
Could be worthwhile Investment >10% per year